Table 1.
Author(s) Country | Neuromodulatory Treatment/Study Design | Group and Intervention Description | Sample Description | Assessment Points and Outcome/Process Variables | Summary of Key Findings |
---|---|---|---|---|---|
Siniatchkin et al. [37] Germany |
NF Non-randomized pilot study |
Groups G1: NF treatment G2: Healthy controls G3: Waiting list Session details Number of sessions: 1 introductory session + 10 training sessions over 8 weeks. Session content:
|
G1: n = 10 80% male Mean age = 10.5 years Dx.: Migraine without aura G2: n = 10 70% male Mean age = 11.6 years Dx.: Healthy children G3: n = 10 80% male Mean age = 9.9 years Dx.: Migraine without aura |
Assessment points
Outcome variables
|
50% of the treatment group presented a 50% or greater reduction in the number of migraines a month after treatment. Migraine duration reductions were observed in treatment and waiting list groups. No significant changes in the waiting list group in accompanying symptoms (nausea, vomiting, intensity of migraine, or medication intake). No significant differences between the treatment group and the waiting list group in medication intake and migraine intensity. Successful suppression of SCPs’ amplitude in the treatment group. |
Stokes & Lappin [38] USA |
NF Case series |
One group only NF + pirHEG + medication Session details Number of sessions: 40 sessions (30 NF + 10 pirHEG/thermal feedback) Session content:
|
n = 13 70% female Mean age = 13.4 years Age range = 9–21 years Dx.: Migraine |
Assessment points
Outcome variable
|
Significant decreases observed in the average number of migraine days from pre-treatment to follow-up. |
Gauntlett-Gilbert et al. [53] United Kingdom |
Meditation Case series |
One group only ACT residential pain management program Session details Sessions duration: 90 h over 3 weeks Session content:
|
n = 98 75% female Mean age = 15.6 years Age range = 10.8–19.0 years Dx.: Idiopathic pain, complex regional pain syndrome, back pain, abdominal pain, pain associated with hypermobility |
Assessment points
Outcome variables
|
Significant pre- to post-treatment improvements observed in physical and social disability, walking distance, pain anxiety, pain catastrophizing, pain acceptance, school attendance and medication use that were maintained at follow-up. Significant pre- to post-treatment improvements in depression and perceived psychosocial development were observed, but these improvements were not maintained at follow-up. Significant pre- to follow up decrease in health care use. No significant differences in pain intensity at post-treatment and follow-up. |
Hesse et al. [50] USA |
Meditation Case series |
One group only MBSR Session details Number of sessions: 8 weekly sessions Session duration: 2 h Session content:
|
n = 20 100% female Mean age = 14.15 years Age range = 11–16 years Dx.: Headache |
Assessment points
Process variables
Outcome variables
|
Average number of sessions attended: 6.10 of 8 total sessions. Average of adherence to daily meditation practice: 4.69 of 6 practices per week. Number (%) who completed treatment: 15 (75%). 53% reported the treatment was helpful in coping with stress, relaxing and controlling their emotions and pain; 40% reported that it was helpful in specific ways (i.e., pain reduction); 13% reported the intervention was not as helpful as expected. 33% reported the intervention not affect their headache, 20% reported having fewer headaches, 13.3% reported having less severe headache, and 7% the headache got better. Significant pre- to post-treatment improvements were observed in depressive symptoms and pain willingness. No significant pre- to post-treatment differences were observed in frequency and severity of headache, disability, quality of life, anxiety, or activity engagement. |
Jastrowski et al. [51] USA |
Meditation Randomized pilot (i.e., very small sample size) study |
Groups G1: MBSR G2: Psycho-educational group Session details Number of sessions: 6 weekly sessions Session duration: 90’ Session content: G1:
G2:
|
G1: N = 4 75% female Mean age = 15.0 years Age range = 12–17 year. Dx.: Chest pain, extremity pain, headache pain, back pain G2: N = 2 100% female Mean age = 12.5 years Age range = 12–13 years Dx.: Abdominal pain |
Assessment points
Process variables
Outcome variables
|
Average number of sessions attended: G1: 4/6 sessions G2: 3/6 sessions In general, participants had positive expectations of the proposed interventions. 75% of the participants in G1 reported expecting that MBSR would be “somewhat” to “completely helpful” at pre-treatment. At 12-week follow-up one participant reported that MBSR was “completely helpful” and another that it was “not at all helpful”. Qualitative individual analyses for outcome variables (data are missing for several participants and for different assessment points) indicate that:
|
Martin et al. [54] USA |
Meditation Case series |
One group only ACT Session details Number of sessions: 3 Session duration: 2 h over 2 days Session content:
|
n = 10 50% girls Mean age = 16.9 years Age range = 12–20 years Dx.: Neurofibromatosis type 1 |
Assessment points
Process variables
Outcomes variables Adolescents:
Parents
|
60% of the participants used mindfulness techniques at least once a week at follow-up. Average participant satisfaction with study was 3.9 on a 0–5 scale. Average parent satisfaction with treatment was 4.6 on a 0–5 scale. Significant pre-treatment to follow-up improvements in pain intensity and pain interference were observed. 60% of the participants reported a decrease of medication at follow-up, relative to pre-treatment. Parents reported a significant pre-treatment to follow-up reduction in pain interference. No significant pre-treatment to follow-up improvements were reported in functional ability, anxiety, depression, quality of life by patient or parent reports, and acceptance of child’s pain. |
Ruskin et al. [52] Canada |
Meditation Pilot uncontrolled clinical study |
One group only MBSR Session details Number sessions: 8 Session duration: 2 h Session content (meditation exercises):
|
n = 16 100% girls Mean age = 5.75 years Age range = 13–17 years Dx.: Neurophatic pain, musculoskeletal pain, abdominal pain, mixed pain, headache |
Assessment points
Process variables
|
Completion rate: 81% Average sessions attendance was 6.4 out of 8 sessions. All participants would recommend the intervention. Average importance of learning and practice mindfulness rated as 4.17 out of 5. Average confidence in use mindfulness rated as 4 out of 5. MBSR rated as being useful to cope with pain and negative emotions and for being more kind with themselves (average rating = 3.67 out of 5). Favorite activities of the treatment included: experiential exercises, meeting others with similar life experiences, group discussions, and learning new techniques to cope with pain. Areas of improvement noted: need of more specific and immediate techniques for managing pain flare-ups, need of more time to share pain stories with other participant, and difficulties with getting to the hospital after a school day. |
Anbar &Zoughbi [64] USA |
Hypnosis Case series |
One group only Hypnosis Session details Number of sessions: Mean of 2 sessions of hypnosis in clinic with a mean of 3.8 sessions (range 1–16) |
n = 30 56.6% female Mean age = 15 years Age range: 10–18 years Dx.: Headache |
Assessment points
Outcome variables
|
96% of the participants reported pre- to post-treatment decreases in headache frequency and intensity. Pre- to post-treatment improvements were maintained at follow-up for 65% of the sample. |
Galini, Shaoul & Mogilner [62] Israel |
Hypnosis Case series |
One group only Hypnosis Session details Number of sessions: 1 |
n = 20 75% female Age range = 11–18 years Dx.: Chronic recurrent functional abdominal pain |
Assessment points
Outcome variables
|
70% of the participants reported pre- to post-treatment improvements in pain intensity and pain frequency. |
Kohen & Zajac [63] USA |
Hypnosis Case series |
One group only Hypnosis Session details Number of sessions: 3 to 4 |
n = 144 66% female Mean age = 11.0 years Age range = 5–15 years Dx.: Headache |
Assessment points
Outcome variables
|
88% of the participants reported a decrease in headache frequency (from 4.5 to 1.4/week), 87% a decrease in headache pain intensity (10.3 to 4.7 in a 12-point scale), and 26% experienced a resolution in their headache. Headache duration decreased from 23.6 to 3.0 h, on average. |
Olness et al. [70] USA |
Hypnosis Randomized controlled trial |
Groups G1: Placebo-placebo-hypnosis G2: Propranolol-placebo-hypnosis G3: Placebo-propranolol-hypnosis Session details Number of sessions: 3 during 12 weeks, 10-week placebo or drug treatment period. |
G1: n = 9 44.4% female Mean age = 8.4 years Age range = 6–12 years Dx.: Migraine G2: n = 11 18.2% female Mean age = 9.6 years Age range = 6–12 years Dx.: Migraine G3: n = 8 62.5% female/male Mean age = 9.6 years Age range = 6–12 years Dx.: Migraine |
Assessment points
Outcome variables
|
Participants in the hypnosis group reported a significantly greater pre- to post-treatment decrease in headache frequency relative to control group, but no significant differences were found regarding pain intensity. |
Van Tilburg et al. [66] USA |
Hypnosis Randomized controlled trial |
Groups G1: Standard medical care + listening to recorded hypnotic sessions G2: Standard medical care Session details (G1) Number of sessions: 3 biweekly sessions, including 1 booster session + 3 daily sessions. Treatment period: 2 months Session content: Listen to tape with self-exercises ≥5 days/week. |
G1: n = 19 G2: n = 15 71% female Age range = 6–16 years Dx: Functional Abdominal Pain |
Assessment points
Outcome variables
|
Participants in the hypnosis group reported significantly greater pre- to post-treatment improvements in pain intensity and perceived “health related quality of life” than participants in the control group. No significant differences between the hypnosis and control groups were observed in school absenteeism or medication use. |
Vlieger et al. [67] Vlieger et al. [68] * Netherlands |
Hypnosis Randomized controlled trial |
Groups G1: Hypnosis G2: Standard medical care + supportive therapy Session details Number of sessions: 6 Session duration: 50’over a 3-month period for the G1. Six 30’ session over a 3-month period for the G2. |
G1: n = 27 67% female G2: n = 22 86% female Mean age = 13.2 years Age range = 8–18 years Dx.: Irritable bowel syndrome, functional abdominal pain |
Assessment points
Outcome variables
|
Participants in the hypnosis group reported significantly greater pre- to post-treatment improvements in pain intensity and frequency. Participants in the hypnosis group reported significantly greater general pain improvement at 1-year and 5-year follow up. No significant differences between the hypnosis and control groups were observed in school absenteeism at a 5-year follow-up. |
Weydert et al. [69] USA |
Hypnosis Randomized controlled trial |
Groups G1: Standard medical care + 4 hypnosis sessions G2: Standard medical care + breathing techniques Session details Number of sessions: 4 weekly sessions Session content: G1: Progressive relaxation + guided imagery. Listen to tape with self-exercises twice a day. G2: Learning three breathing techniques. |
G1: n = 14 77% female Mean age = 11.0 years Dx.: Abdominal pain G2: n = 8 50% female Mean age = 11.1 years Dx.: Abdominal pain |
Assessment points
Outcome variables
|
Participants in the hypnosis group reported significantly greater pre- to post-treatment improvements in pain frequency that were maintained at 1-month follow up. Participants in the hypnosis group reported significantly greater pre- to post-treatment improvements in school absenteeism that were maintained at 1-month follow up. |
Zeltzer et al. [65] USA |
Hypnosis Case series |
One group only Hypnosis Session details Number of sessions: 6 weekly sessions Session content: acupuncture combined with 20′ of hypnotic sessions. |
n = 31 61% female Mean age = 13 years Age range = 6–18 years Dx.: Headache, abdominal pain associated with irritable bowel syndrome, fibromyalgia, complex regional pain syndrome, juvenile rheumatoid arthritis, myofascial back and chest pain |
Assessment points
Outcome variables
|
Children: Participants reported significantly greater pre- to post-treatment improvements in current and average pain intensity; 42.5% of children reported a decrease in current pain. Participants reported significantly greater pre- to post-treatment improvements in pain interference in functioning. Participants reported significantly greater pre- to post-treatment improvements in anxiety (50% of children reported decrease). No significant changes were reported in depression. Parents: Parents reported significantly greater pre- to post-treatment improvements in current and average pain intensity as well as pain interference in functioning. |
* This publication reports on the five-year follow-up of the sample. Data from there participants of the control group are missing; NF: Neurofeedback; SCP: Slow Cortical Potentials; pirHEG: passive infrared hemoencephalography; CNV: Contingent Negative Variation; ACT: Acceptance and Commitment Therapy; MBSR: Mindfulness-based stress reduction; T: temporal area; C: central area; F: frontal area; FP: prefrontal area; P: parietal area; G: group; n: number of participants; Dx.: Diagnosis.